136 related articles for article (PubMed ID: 37919902)
21. FKRP-dependent glycosylation of fibronectin regulates muscle pathology in muscular dystrophy.
Wood AJ; Lin CH; Li M; Nishtala K; Alaei S; Rossello F; Sonntag C; Hersey L; Miles LB; Krisp C; Dudczig S; Fulcher AJ; Gibertini S; Conroy PJ; Siegel A; Mora M; Jusuf P; Packer NH; Currie PD
Nat Commun; 2021 May; 12(1):2951. PubMed ID: 34012031
[TBL] [Abstract][Full Text] [Related]
22. Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I.
Azzag K; Ortiz-Cordero C; Oliveira NAJ; Magli A; Selvaraj S; Tungtur S; Upchurch W; Iaizzo PA; Lu QL; Perlingeiro RCR
Skelet Muscle; 2020 Apr; 10(1):10. PubMed ID: 32321586
[TBL] [Abstract][Full Text] [Related]
23. Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery.
Qiao C; Wang CH; Zhao C; Lu P; Awano H; Xiao B; Li J; Yuan Z; Dai Y; Martin CB; Li J; Lu Q; Xiao X
Mol Ther; 2014 Nov; 22(11):1890-9. PubMed ID: 25048216
[TBL] [Abstract][Full Text] [Related]
24. FKRP mutations cause congenital muscular dystrophy 1C and limb-girdle muscular dystrophy 2I in Asian patients.
Awano H; Saito Y; Shimizu M; Sekiguchi K; Niijima S; Matsuo M; Maegaki Y; Izumi I; Kikuchi C; Ishibashi M; Okazaki T; Komaki H; Iijima K; Nishino I
J Clin Neurosci; 2021 Oct; 92():215-221. PubMed ID: 34509255
[TBL] [Abstract][Full Text] [Related]
25. FKRP directed fibronectin glycosylation: A novel mechanism giving insights into muscular dystrophies?
Boyd A; Montandon M; Wood AJ; Currie PD
Bioessays; 2022 May; 44(5):e2100270. PubMed ID: 35229908
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies.
Ackroyd MR; Skordis L; Kaluarachchi M; Godwin J; Prior S; Fidanboylu M; Piercy RJ; Muntoni F; Brown SC
Brain; 2009 Feb; 132(Pt 2):439-51. PubMed ID: 19155270
[TBL] [Abstract][Full Text] [Related]
27. Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression.
Kanagawa M; Yu CC; Ito C; Fukada S; Hozoji-Inada M; Chiyo T; Kuga A; Matsuo M; Sato K; Yamaguchi M; Ito T; Ohtsuka Y; Katanosaka Y; Miyagoe-Suzuki Y; Naruse K; Kobayashi K; Okada T; Takeda S; Toda T
Hum Mol Genet; 2013 Aug; 22(15):3003-15. PubMed ID: 23562821
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Gene Therapy Is Dependent on Disease Progression in Dystrophic Mice with Mutations in the FKRP Gene.
Vannoy CH; Xiao W; Lu P; Xiao X; Lu QL
Mol Ther Methods Clin Dev; 2017 Jun; 5():31-42. PubMed ID: 28480302
[TBL] [Abstract][Full Text] [Related]
29. Novel FKRP mutations in a Japanese MDC1C sibship clinically diagnosed with Fukuyama congenital muscular dystrophy.
Yoshioka M; Kobayashi K; Toda T
Brain Dev; 2017 Nov; 39(10):869-872. PubMed ID: 28629604
[TBL] [Abstract][Full Text] [Related]
30. Oral ribose supplementation in dystroglycanopathy: A single case study.
Thewissen RMJ; Post MA; Maas DM; Veizaj R; Wagenaar I; Alsady M; Kools J; Bouman K; Zweers H; Meregalli PG; van der Kooi AJ; van Doorn PA; Groothuis JT; Lefeber DJ; Voermans NC
JIMD Rep; 2024 May; 65(3):171-181. PubMed ID: 38736632
[TBL] [Abstract][Full Text] [Related]
31. A universal gene correction approach for FKRP-associated dystroglycanopathies to enable autologous cell therapy.
Dhoke NR; Kim H; Selvaraj S; Azzag K; Zhou H; Oliveira NAJ; Tungtur S; Ortiz-Cordero C; Kiley J; Lu QL; Bang AG; Perlingeiro RCR
Cell Rep; 2021 Jul; 36(2):109360. PubMed ID: 34260922
[TBL] [Abstract][Full Text] [Related]
32. Chemical and Chemo-Enzymatic Syntheses of Glycans Containing Ribitol Phosphate Scaffolding of Matriglycan.
Tamura JI; Tamura T; Hoshino S; Imae R; Kato R; Yokono M; Nagase M; Ohno S; Manabe N; Yamaguchi Y; Manya H; Endo T
ACS Chem Biol; 2022 Jun; 17(6):1513-1523. PubMed ID: 35670527
[TBL] [Abstract][Full Text] [Related]
33. Post-Natal knockdown of fukutin-related protein expression in muscle by long-termRNA interference induces dystrophic pathology [corrected].
Wang CH; Chan YM; Tang RH; Xiao B; Lu P; Keramaris-Vrantsis E; Zheng H; Qiao C; Jiang J; Li J; Ma HI; Lu Q; Xiao X
Am J Pathol; 2011 Jan; 178(1):261-72. PubMed ID: 21224063
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory machinery for the functional dystroglycan glycosylation.
Kondo Y; Okajima T
J Biochem; 2023 Apr; 173(5):333-335. PubMed ID: 36760122
[TBL] [Abstract][Full Text] [Related]
35. Break Down of the Complexity and Inconsistency Between Levels of Matriglycan and Disease Phenotype in FKRP-Related Dystroglycanopathies: A Review and Model of Interpretation.
Lu QL; Holbrook MC; Cataldi MP; Blaeser A
J Neuromuscul Dis; 2024; 11(2):275-284. PubMed ID: 38277301
[TBL] [Abstract][Full Text] [Related]
36. Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth.
Lu PJ; Tucker JD; Branch EK; Guo F; Blaeser AR; Lu QL
Sci Rep; 2020 Mar; 10(1):4935. PubMed ID: 32188898
[TBL] [Abstract][Full Text] [Related]
37. Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies.
Chan YM; Keramaris-Vrantsis E; Lidov HG; Norton JH; Zinchenko N; Gruber HE; Thresher R; Blake DJ; Ashar J; Rosenfeld J; Lu QL
Hum Mol Genet; 2010 Oct; 19(20):3995-4006. PubMed ID: 20675713
[TBL] [Abstract][Full Text] [Related]
38. Elevated serum creatine kinase and small cerebellum prompt diagnosis of congenital muscular dystrophy due to FKRP mutations.
Trovato R; Astrea G; Bartalena L; Ghirri P; Baldacci J; Giampietri M; Battini R; Santorelli FM; Fiorillo C
J Child Neurol; 2014 Mar; 29(3):394-8. PubMed ID: 23420653
[TBL] [Abstract][Full Text] [Related]
39. CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model.
Tokuoka H; Imae R; Nakashima H; Manya H; Masuda C; Hoshino S; Kobayashi K; Lefeber DJ; Matsumoto R; Okada T; Endo T; Kanagawa M; Toda T
Nat Commun; 2022 Apr; 13(1):1847. PubMed ID: 35422047
[TBL] [Abstract][Full Text] [Related]
40. Functional requirements for fukutin-related protein in the Golgi apparatus.
Esapa CT; Benson MA; Schröder JE; Martin-Rendon E; Brockington M; Brown SC; Muntoni F; Kröger S; Blake DJ
Hum Mol Genet; 2002 Dec; 11(26):3319-31. PubMed ID: 12471058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
